131 related articles for article (PubMed ID: 3498041)
21. Rapid degradation of articular cartilage proteoglycan by neutrophils: comparison with macrophages and synovial fibroblasts.
Halliday DA; Clemente G; Rathjen DA; Ferrante A
Inflamm Res; 2000 Sep; 49(9):441-4. PubMed ID: 11071117
[TBL] [Abstract][Full Text] [Related]
22. Factors influencing the oxygen concentration gradient from the synovial surface of articular cartilage to the cartilage-bone interface: a modeling study.
Zhou S; Cui Z; Urban JP
Arthritis Rheum; 2004 Dec; 50(12):3915-24. PubMed ID: 15593204
[TBL] [Abstract][Full Text] [Related]
23. Effects of R and S enantiomers and a racemic mixture of carprofen on the production and release of proteoglycan and prostaglandin E2 from equine chondrocytes and cartilage explants.
Armstrong S; Lees P
Am J Vet Res; 1999 Jan; 60(1):98-104. PubMed ID: 9918155
[TBL] [Abstract][Full Text] [Related]
24. Enhanced breakdown in vitro of bovine articular cartilage proteoglycans by conditional synovial medium. The effect of superoxide dismutase and catalase.
Klämfeldt A; Marklund S
Scand J Rheumatol; 1987; 16(1):41-5. PubMed ID: 3589589
[TBL] [Abstract][Full Text] [Related]
25. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
Milner JM; Elliott SF; Cawston TE
Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
[TBL] [Abstract][Full Text] [Related]
26. Use of the guinea pig myectomy osteoarthritis model in the examination of cartilage-synovium interactions.
Layton MW; Arsever C; Bole GG
J Rheumatol; 1987 May; 14 Spec No():125-6. PubMed ID: 3625666
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product, hymenialdisine.
Badger AM; Cook MN; Swift BA; Newman-Tarr TM; Gowen M; Lark M
J Pharmacol Exp Ther; 1999 Aug; 290(2):587-93. PubMed ID: 10411566
[TBL] [Abstract][Full Text] [Related]
28. Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4.
Lubberts E; Joosten LA; van de Loo FA; van den Gersselaar LA; van den Berg WB
Arthritis Rheum; 2000 Jun; 43(6):1300-6. PubMed ID: 10857788
[TBL] [Abstract][Full Text] [Related]
29. Degradation of cartilage proteoglycan and collagen by synovial cells. Stimulation by macrophages under activation by phagocytosis, lymphocyte factors, bacterial products or other inflammatory stimuli.
Peeters-Joris C; Vaes G
Biochim Biophys Acta; 1984 Aug; 804(4):474-86. PubMed ID: 6466714
[TBL] [Abstract][Full Text] [Related]
30. Effects of indomethacin on joint damage in rat and rabbit.
Wang B; Yao YY; Chen MZ
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):70-3. PubMed ID: 10375764
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of transforming growth factor beta production by nitric oxide-treated chondrocytes: implications for matrix synthesis.
Studer RK; Georgescu HI; Miller LA; Evans CH
Arthritis Rheum; 1999 Feb; 42(2):248-57. PubMed ID: 10025918
[TBL] [Abstract][Full Text] [Related]
32. Elastase secreted by activated polymorphonuclear leucocytes causes chondrocyte damage and matrix degradation in intact articular cartilage: escape from inactivation by alpha-1-proteinase inhibitor.
Schalkwijk J; van den Berg WB; van de Putte LB; Joosten LA
Br J Exp Pathol; 1987 Feb; 68(1):81-8. PubMed ID: 3493025
[TBL] [Abstract][Full Text] [Related]
33. Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis.
Xie DL; Hui F; Meyers R; Homandberg GA
Arch Biochem Biophys; 1994 Jun; 311(2):205-12. PubMed ID: 8203882
[TBL] [Abstract][Full Text] [Related]
34. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts.
Neidhart M; Gay RE; Gay S
Arthritis Rheum; 2000 Aug; 43(8):1719-28. PubMed ID: 10943861
[TBL] [Abstract][Full Text] [Related]
35. Effect of interleukin 1 on articular cartilage from young and aged horses and comparison with metabolism of osteoarthritic cartilage.
Morris EA; Treadwell BV
Am J Vet Res; 1994 Jan; 55(1):138-46. PubMed ID: 8141486
[TBL] [Abstract][Full Text] [Related]
36. Divergent effects of suramin on in vitro and in vivo assays of cartilage degradation.
Ackerman NR; Jubb S; Trimble B; Marlowe S; Miram L; Maloney P
J Pharmacol Exp Ther; 1983 May; 225(2):243-50. PubMed ID: 6341539
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of hyperosmotic challenge on interleukin-1-activated pathways in bovine articular cartilage.
Le D; Hofbauer MA; Towle CA
Arch Biochem Biophys; 2006 Jan; 445(1):1-8. PubMed ID: 16359637
[TBL] [Abstract][Full Text] [Related]
38. Synovial cartilage interactions with special reference to the prostanoids as metabolic agents in cartilage under normal and pathological conditions.
Mitrovic D
Eur J Rheumatol Inflamm; 1982; 5(1):3-14. PubMed ID: 7044794
[No Abstract] [Full Text] [Related]
39. Enhanced breakdown of bovine articular cartilage proteoglycans by conditioned synovial medium. The effect of serum and dextran sulphate.
Jones IL; Klämfeldt A; McGuire MB
Scand J Rheumatol; 1982; 11(1):41-6. PubMed ID: 6175020
[TBL] [Abstract][Full Text] [Related]
40. Effects of the hydroxamic acid derivate Ro 31-4724 on the metabolism and morphology of interleukin-1-treated cartilage explants.
Steinmeyer J; Daufeldt S; Kalbhen DA
Pharmacology; 1997 Aug; 55(2):95-108. PubMed ID: 9323309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
